Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

NCT07533266 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

NSAID (Non-Steroidal Anti-Inflammatory Drug)

Interventions

DRUG: Fexuprazan 20mg
DRUG: Lansoprazole 15 mg placebo
DRUG: Lansoprazole 15 mg
DRUG: Fexuprazan 20mg placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.